About Us
BDSRA is dedicated to funding research for treatments and cures, providing family support services, advancing education, raising awareness, and advocating for legislative action. Founded in 1987, by parents seeking to build a network for those diagnosed with Batten disease, BDSRA is now the largest support and research organization dedicated to Batten disease in North America. BDSRA believes that to effectively unravel the mysteries of Batten disease, the worlds of medical science, research, and families must work together toward a common goal: discover treatments and cures while assuring a better quality of life for those living with the disease.
Recent News
Historic Milestone for Batten Disease: Ohio Unanimously Recommends CLN2 Newborn Screening
November 12, 2026 | Columbus, Ohio — The Batten Disease Support, Research, and Advocacy (BDSRA) Foundation welcomes a historic milestone following the Ohio Newborn Screening Advisory Council's unanimous vote on November 6, recommending CLN2 disease for inclusion in the state's newborn screening panel. Believed to be the first such recommendation worldwide, the decision represents a significant step towards making CLN2 disease the first form of Batten disease to be routinely screened for at birth. CLN2 disease, also known [...]
CLN7 Community News
Dear CLN7 Community, Over the last several months, there have been many questions and, unfortunately, some conflicting information circulating regarding the CLN7 clinical program. We recognize how difficult this uncertainty is for families waiting for potential treatment and want to provide an update on where the program stands and what families can expect next. In March 2026, Julinha was treated at UTSW with a dose equivalent to the dose previously administered to patients in the prior high-dose [...]











